Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC).
Abrisqueta P, González-Barca E, Ferrà C, Ríos-Herranz E, Fernández de la Mata M, Delgado J, Andreu R, Hernández-Rivas JÁ, Terol MJ, Navarro A, Vidriales MB, Baltasar P, De la Serna J, Ramírez Á, Ballester C, Moreno C, García-Marco JA, Córdoba R, Yáñez L, Casado LF, González M, Bosch F. Abrisqueta P, et al. Among authors: vidriales mb. EClinicalMedicine. 2024 May 25;73:102642. doi: 10.1016/j.eclinm.2024.102642. eCollection 2024 Jul. EClinicalMedicine. 2024. PMID: 38841711 Free PMC article.
Characterization of aberrant phenotypes in acute myeloblastic leukemia.
Macedo A, Orfão A, Vidriales MB, López-Berges MC, Valverde B, González M, Caballero MD, Ramos F, Martínez M, Fernández-Calvo J, et al. Macedo A, et al. Among authors: vidriales mb. Ann Hematol. 1995 Apr;70(4):189-94. doi: 10.1007/BF01700374. Ann Hematol. 1995. PMID: 7748963
Prognostic value of S-phase cells in AML patients.
Vidriales MB, Orfao A, López-Berges MC, González M, López-Macedo A, Ciudad J, López A, García MA, Hernández J, Borrego D, et al. Vidriales MB, et al. Br J Haematol. 1995 Feb;89(2):342-8. doi: 10.1111/j.1365-2141.1995.tb03310.x. Br J Haematol. 1995. PMID: 7873384
Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification.
San Miguel JF, Vidriales MB, López-Berges C, Díaz-Mediavilla J, Gutiérrez N, Cañizo C, Ramos F, Calmuntia MJ, Pérez JJ, González M, Orfao A. San Miguel JF, et al. Among authors: vidriales mb. Blood. 2001 Sep 15;98(6):1746-51. doi: 10.1182/blood.v98.6.1746. Blood. 2001. PMID: 11535507 Free article.
110 results